📰 Varuna News
Page 14 - Varuna News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Varuna. Real-time updates on events, politics, business and more.
December 30, 2023
In a press statement, the Forest department officials said Vikram avoided appearing before the Investigating Officer (IO) earlier when he was summoned for questioning.
December 28, 2023
Going beyond infrastructural issues, Indias logistics sector has a lot to grapple with. One easy solution could be digital integration.
December 27, 2023
1st Avatar of Vishnu, what is the first Avatar of Lord Vishnu. Importance of 1st Avatar of Vishnu, significance of 1st Avatar of Vishnu, story of 1st Avatar of Vishnu.
December 25, 2023
Varanasi: Lalpur-Pandeupyr police arrested five members of a gang of thieves targeting temples for theft of cash and valuables, on Sunday.
December 24, 2023
Mysuru: CM Siddaramaiah on Saturday stated that if the industries didn’t recruit locals, the purpose of industrialisation would be defeated.
December 24, 2023
CM Siddaramaiah announced that the government is ready to implement the ropeway project to Chamundi Hill in Mysuru and urged green activists not to oppose it. Learn more about the importance of the hotel industry in promoting tourism and the demands of the Hotel Owners' Association.
December 22, 2023
DENPASAR, Indonesia, Dec. 22, 2023 /PRNewswire/ -- As the end of the year approaches, the holiday season is one that many people look forward to. For those
December 22, 2023
New York-based Bristol has been under pressure to expand its drug pipeline amid declining demand for two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. "We expect KarXT to enhance our growth through the late 2020s and into the next decade," CEO Christopher Boerner said in a statement. Under the terms of the deal, Bristol would pay $330 a share in cash for Karuna, which represents a 53.4% premium to its last closing price.
December 22, 2023
New York-based Bristol has been under pressure to expand its drug pipeline amid declining demand for two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, which face generic competition. "We expect KarXT to enhance our growth through the late 2020s and into the next decade," CEO Christopher Boerner said in a statement. Under the terms of the deal, Bristol would pay $330 a share in cash for Karuna, which represents a 53.4% premium to its last closing price.
December 20, 2023
The Global Unmanned Aerial Vehicle (UAV) Market Covered Major Segments By Class (Small UAVs, Tactical UAVs, and Strategic UAVs), By Technology (Remotely...